1 Study Coverage 1.1 Human VEGF Antibody Product Introduction 1.2 Market by Type 1.2.1 Global Human VEGF Antibody Market Size Growth Rate by Type 1.4.2 Rabbit 1.4.3 Mouse 1.2.4 Goat 1.2.5 Others 1.3 Market by Application 1.3.1 Global Human VEGF Antibody Market Size Growth Rate by Application 1.3.2 Laboratory 1.3.3 Hospital 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Human VEGF Antibody Sales Estimates and Forecasts 2016-2027 2.2 Global Human VEGF Antibody Revenue Estimates and Forecasts 2016-2027 2.3 Global Human VEGF Antibody Revenue by Region: 2016 VS 2021 VS 2027 2.4 Global Top Human VEGF Antibody Regions by Sales 2.4.1 Global Top Human VEGF Antibody Regions by Sales (2016-2021) 2.4.2 Global Top Human VEGF Antibody Regions by Sales (2022-2027) 2.5 Global Top Human VEGF Antibody Regions by Revenue 2.5.1 Global Top Human VEGF Antibody Regions by Revenue (2016-2021) 2.5.2 Global Top Human VEGF Antibody Regions by Revenue (2022-2027) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Human VEGF Antibody Sales by Manufacturers 3.1.1 Global Top Human VEGF Antibody Manufacturers by Sales (2016-2021) 3.1.2 Global Top Human VEGF Antibody Manufacturers Market Share by Sales (2016-2021) 3.1.3 Global Top 10 and Top 5 Companies by Human VEGF Antibody Sales in 2020 3.2 Global Human VEGF Antibody Revenue by Manufacturers 3.2.1 Global Top Human VEGF Antibody Manufacturers by Revenue (2016-2021) 3.2.2 Global Top Human VEGF Antibody Manufacturers Market Share by Revenue (2016-2021) 3.2.3 Global Top 10 and Top 5 Companies by Human VEGF Antibody Revenue in 2020 3.3 Global Human VEGF Antibody Sales Price by Manufacturers 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Human VEGF Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Human VEGF Antibody Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Human VEGF Antibody Sales by Type 4.1.1 Global Human VEGF Antibody Historical Sales by Type (2016-2021) 4.1.2 Global Human VEGF Antibody Forecasted Sales by Type (2022-2027) 4.1.3 Global Human VEGF Antibody Sales Market Share by Type (2016-2027) 4.2 Global Human VEGF Antibody Revenue by Type 4.2.1 Global Human VEGF Antibody Historical Revenue by Type (2016-2021) 4.2.2 Global Human VEGF Antibody Forecasted Revenue by Type (2022-2027) 4.2.3 Global Human VEGF Antibody Revenue Market Share by Type (2016-2027) 4.3 Global Human VEGF Antibody Price by Type 4.3.1 Global Human VEGF Antibody Price by Type (2016-2021) 4.3.2 Global Human VEGF Antibody Price Forecast by Type (2022-2027) 5 Market Size by Application 5.1 Global Human VEGF Antibody Sales by Application 5.1.1 Global Human VEGF Antibody Historical Sales by Application (2016-2021) 5.1.2 Global Human VEGF Antibody Forecasted Sales by Application (2022-2027) 5.1.3 Global Human VEGF Antibody Sales Market Share by Application (2016-2027) 5.2 Global Human VEGF Antibody Revenue by Application 5.2.1 Global Human VEGF Antibody Historical Revenue by Application (2016-2021) 5.2.2 Global Human VEGF Antibody Forecasted Revenue by Application (2022-2027) 5.2.3 Global Human VEGF Antibody Revenue Market Share by Application (2016-2027) 5.3 Global Human VEGF Antibody Price by Application 5.3.1 Global Human VEGF Antibody Price by Application (2016-2021) 5.3.2 Global Human VEGF Antibody Price Forecast by Application (2022-2027) 6 North America 6.1 North America Human VEGF Antibody Market Size by Type 6.1.1 North America Human VEGF Antibody Sales by Type (2016-2027) 6.1.2 North America Human VEGF Antibody Revenue by Type (2016-2027) 6.2 North America Human VEGF Antibody Market Size by Application 6.2.1 North America Human VEGF Antibody Sales by Application (2016-2027) 6.2.2 North America Human VEGF Antibody Revenue by Application (2016-2027) 6.3 North America Human VEGF Antibody Market Size by Country 6.3.1 North America Human VEGF Antibody Sales by Country (2016-2027) 6.3.2 North America Human VEGF Antibody Revenue by Country (2016-2027) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Human VEGF Antibody Market Size by Type 7.1.1 Europe Human VEGF Antibody Sales by Type (2017-2027) 7.1.2 Europe Human VEGF Antibody Revenue by Type (2017-2027) 7.2 Europe Human VEGF Antibody Market Size by Application 7.2.1 Europe Human VEGF Antibody Sales by Application (2017-2027) 7.2.2 Europe Human VEGF Antibody Revenue by Application (2017-2027) 7.3 Europe Human VEGF Antibody Market Size by Country 7.3.1 Europe Human VEGF Antibody Sales by Country (2017-2027) 7.3.2 Europe Human VEGF Antibody Revenue by Country (2017-2027) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Human VEGF Antibody Market Size by Type 8.1.1 Asia Pacific Human VEGF Antibody Sales by Type (2018-2027) 8.1.2 Asia Pacific Human VEGF Antibody Revenue by Type (2018-2027) 8.2 Asia Pacific Human VEGF Antibody Market Size by Application 8.2.1 Asia Pacific Human VEGF Antibody Sales by Application (2018-2027) 8.2.2 Asia Pacific Human VEGF Antibody Revenue by Application (2018-2027) 8.3 Asia Pacific Human VEGF Antibody Market Size by Region 8.3.1 Asia Pacific Human VEGF Antibody Sales by Region (2018-2027) 8.3.2 Asia Pacific Human VEGF Antibody Revenue by Region (2018-2027) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Human VEGF Antibody Market Size by Type 9.1.1 Latin America Human VEGF Antibody Sales by Type (2019-2027) 9.1.2 Latin America Human VEGF Antibody Revenue by Type (2019-2027) 9.2 Latin America Human VEGF Antibody Market Size by Application 9.2.1 Latin America Human VEGF Antibody Sales by Application (2019-2027) 9.2.2 Latin America Human VEGF Antibody Revenue by Application (2019-2027) 9.3 Latin America Human VEGF Antibody Market Size by Country 9.3.1 Latin America Human VEGF Antibody Sales by Country (2019-2027) 9.3.2 Latin America Human VEGF Antibody Revenue by Country (2019-2027) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 6 Middle East and Africa 6.1 Middle East and Africa Human VEGF Antibody Market Size by Type 6.1.1 Middle East and Africa Human VEGF Antibody Sales by Type (2016-2027) 6.1.2 Middle East and Africa Human VEGF Antibody Revenue by Type (2016-2027) 6.2 Middle East and Africa Human VEGF Antibody Market Size by Application 6.2.1 Middle East and Africa Human VEGF Antibody Sales by Application (2016-2027) 6.2.2 Middle East and Africa Human VEGF Antibody Revenue by Application (2016-2027) 6.3 Middle East and Africa Human VEGF Antibody Market Size by Country 6.3.1 Middle East and Africa Human VEGF Antibody Sales by Country (2016-2027) 6.3.2 Middle East and Africa Human VEGF Antibody Revenue by Country (2016-2027) 6.3.3 Turkey 6.3.4 Saudi Arabia 6.3.5 UAE 11 Company Profiles 11.1 Thermo Fisher 11.1.1 Thermo Fisher Corporation Information 11.1.2 Thermo Fisher Overview 11.1.3 Thermo Fisher Human VEGF Antibody Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Thermo Fisher Human VEGF Antibody Product Description 11.1.5 Thermo Fisher Related Developments 11.2 MilliporeSigma 11.2.1 MilliporeSigma Corporation Information 11.2.2 MilliporeSigma Overview 11.2.3 MilliporeSigma Human VEGF Antibody Sales, Price, Revenue and Gross Margin (2016-2021) 11.2.4 MilliporeSigma Human VEGF Antibody Product Description 11.2.5 MilliporeSigma Related Developments 11.3 Santa Cruz Biotechnology 11.3.1 Santa Cruz Biotechnology Corporation Information 11.3.2 Santa Cruz Biotechnology Overview 11.3.3 Santa Cruz Biotechnology Human VEGF Antibody Sales, Price, Revenue and Gross Margin (2016-2021) 11.3.4 Santa Cruz Biotechnology Human VEGF Antibody Product Description 11.3.5 Santa Cruz Biotechnology Related Developments 11.4 Abcam 11.4.1 Abcam Corporation Information 11.4.2 Abcam Overview 11.4.3 Abcam Human VEGF Antibody Sales, Price, Revenue and Gross Margin (2016-2021) 11.4.4 Abcam Human VEGF Antibody Product Description 11.4.5 Abcam Related Developments 11.5 R&D Systems 11.5.1 R&D Systems Corporation Information 11.5.2 R&D Systems Overview 11.5.3 R&D Systems Human VEGF Antibody Sales, Price, Revenue and Gross Margin (2016-2021) 11.5.4 R&D Systems Human VEGF Antibody Product Description 11.5.5 R&D Systems Related Developments 11.6 Novus Biologicals 11.6.1 Novus Biologicals Corporation Information 11.6.2 Novus Biologicals Overview 11.6.3 Novus Biologicals Human VEGF Antibody Sales, Price, Revenue and Gross Margin (2016-2021) 11.6.4 Novus Biologicals Human VEGF Antibody Product Description 11.6.5 Novus Biologicals Related Developments 11.7 Abnova 11.7.1 Abnova Corporation Information 11.7.2 Abnova Overview 11.7.3 Abnova Human VEGF Antibody Sales, Price, Revenue and Gross Margin (2016-2021) 11.7.4 Abnova Human VEGF Antibody Product Description 11.7.5 Abnova Related Developments 11.8 ImmunoStar 11.8.1 ImmunoStar Corporation Information 11.8.2 ImmunoStar Overview 11.8.3 ImmunoStar Human VEGF Antibody Sales, Price, Revenue and Gross Margin (2016-2021) 11.8.4 ImmunoStar Human VEGF Antibody Product Description 11.8.5 ImmunoStar Related Developments 11.9 OriGene 11.9.1 OriGene Corporation Information 11.9.2 OriGene Overview 11.9.3 OriGene Human VEGF Antibody Sales, Price, Revenue and Gross Margin (2016-2021) 11.9.4 OriGene Human VEGF Antibody Product Description 11.9.5 OriGene Related Developments 11.10 LifeSpan Biosciences 11.10.1 LifeSpan Biosciences Corporation Information 11.10.2 LifeSpan Biosciences Overview 11.10.3 LifeSpan Biosciences Human VEGF Antibody Sales, Price, Revenue and Gross Margin (2016-2021) 11.10.4 LifeSpan Biosciences Human VEGF Antibody Product Description 11.10.5 LifeSpan Biosciences Related Developments 11.1 Thermo Fisher 11.1.1 Thermo Fisher Corporation Information 11.1.2 Thermo Fisher Overview 11.1.3 Thermo Fisher Human VEGF Antibody Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Thermo Fisher Human VEGF Antibody Product Description 11.1.5 Thermo Fisher Related Developments 11.12 Bio-Rad 11.12.1 Bio-Rad Corporation Information 11.12.2 Bio-Rad Overview 11.12.3 Bio-Rad Human VEGF Antibody Sales, Price, Revenue and Gross Margin (2016-2021) 11.12.4 Bio-Rad Product Description 11.12.5 Bio-Rad Related Developments 11.13 BioLegend 11.13.1 BioLegend Corporation Information 11.13.2 BioLegend Overview 11.13.3 BioLegend Human VEGF Antibody Sales, Price, Revenue and Gross Margin (2016-2021) 11.13.4 BioLegend Product Description 11.13.5 BioLegend Related Developments 11.14 Rockland Immunochemicals 11.14.1 Rockland Immunochemicals Corporation Information 11.14.2 Rockland Immunochemicals Overview 11.14.3 Rockland Immunochemicals Human VEGF Antibody Sales, Price, Revenue and Gross Margin (2016-2021) 11.14.4 Rockland Immunochemicals Product Description 11.14.5 Rockland Immunochemicals Related Developments 11.15 Agrisera 11.15.1 Agrisera Corporation Information 11.15.2 Agrisera Overview 11.15.3 Agrisera Human VEGF Antibody Sales, Price, Revenue and Gross Margin (2016-2021) 11.15.4 Agrisera Product Description 11.15.5 Agrisera Related Developments 11.16 Boster 11.16.1 Boster Corporation Information 11.16.2 Boster Overview 11.16.3 Boster Human VEGF Antibody Sales, Price, Revenue and Gross Margin (2016-2021) 11.16.4 Boster Product Description 11.16.5 Boster Related Developments 11.17 ProMab 11.17.1 ProMab Corporation Information 11.17.2 ProMab Overview 11.17.3 ProMab Human VEGF Antibody Sales, Price, Revenue and Gross Margin (2016-2021) 11.17.4 ProMab Product Description 11.17.5 ProMab Related Developments 11.18 Creative Biomart 11.18.1 Creative Biomart Corporation Information 11.18.2 Creative Biomart Overview 11.18.3 Creative Biomart Human VEGF Antibody Sales, Price, Revenue and Gross Margin (2016-2021) 11.18.4 Creative Biomart Product Description 11.18.5 Creative Biomart Related Developments 11.19 Enzo Life Sciences 11.19.1 Enzo Life Sciences Corporation Information 11.19.2 Enzo Life Sciences Overview 11.19.3 Enzo Life Sciences Human VEGF Antibody Sales, Price, Revenue and Gross Margin (2016-2021) 11.19.4 Enzo Life Sciences Product Description 11.19.5 Enzo Life Sciences Related Developments 11.20 Bon Opus Biosciences 11.20.1 Bon Opus Biosciences Corporation Information 11.20.2 Bon Opus Biosciences Overview 11.20.3 Bon Opus Biosciences Human VEGF Antibody Sales, Price, Revenue and Gross Margin (2016-2021) 11.20.4 Bon Opus Biosciences Product Description 11.20.5 Bon Opus Biosciences Related Developments 11.21 Absolute Antibody 11.21.1 Absolute Antibody Corporation Information 11.21.2 Absolute Antibody Overview 11.21.3 Absolute Antibody Human VEGF Antibody Sales, Price, Revenue and Gross Margin (2016-2021) 11.21.4 Absolute Antibody Product Description 11.21.5 Absolute Antibody Related Developments 11.22 US Biological 11.22.1 US Biological Corporation Information 11.22.2 US Biological Overview 11.22.3 US Biological Human VEGF Antibody Sales, Price, Revenue and Gross Margin (2016-2021) 11.22.4 US Biological Product Description 11.22.5 US Biological Related Developments 12 Value Chain and Sales Channels Analysis 12.1 Human VEGF Antibody Value Chain Analysis 12.2 Human VEGF Antibody Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Human VEGF Antibody Production Mode & Process 12.4 Human VEGF Antibody Sales and Marketing 12.4.1 Human VEGF Antibody Sales Channels 12.4.2 Human VEGF Antibody Distributors 12.5 Human VEGF Antibody Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Human VEGF Antibody Industry Trends 13.2 Human VEGF Antibody Market Drivers 13.3 Human VEGF Antibody Market Challenges 13.4 Human VEGF Antibody Market Restraints 14 Key Findings in The Global Human VEGF Antibody Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Human VEGF Antibody Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Rabbit Table 3. Major Manufacturers of Mouse Table 4. Major Manufacturers of Goat Table 5. Major Manufacturers of Others Table 6. Global Human VEGF Antibody Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 7. Global Human VEGF Antibody Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 8. Global Human VEGF Antibody Sales by Region (2016-2021) & (Kg) Table 9. Global Human VEGF Antibody Sales Market Share by Region (2016-2021) Table 10. Global Human VEGF Antibody Sales by Region (2016-2021) & (Kg) Table 11. Global Human VEGF Antibody Sales Market Share by Region (2022-2027) Table 12. Global Human VEGF Antibody Revenue by Region (2016-2021) & (US$ Million) Table 13. Global Human VEGF Antibody Revenue Market Share by Region (2016-2021) Table 14. Global Human VEGF Antibody Revenue by Region (2022-2027) & (US$ Million) Table 15. Global Human VEGF Antibody Revenue Market Share by Region (2022-2027) Table 16. Global Human VEGF Antibody Sales by Manufacturers (2016-2021) & (Kg) Table 17. Global Human VEGF Antibody Sales Share by Manufacturers (2016-2021) Table 18. Global Human VEGF Antibody Revenue by Manufacturers (2016-2021) & (US$ Million) Table 19. Global Human VEGF Antibody Revenue Share by Manufacturers (2016-2021) Table 20. Human VEGF Antibody Price by Manufacturers 2016-2021 (USD/g) Table 21. Global Human VEGF Antibody Manufacturers Market Concentration Ratio (CR5 and HHI) Table 22. Global Human VEGF Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human VEGF Antibody as of 2020) Table 23. Human VEGF Antibody Manufacturing Base Distribution and Headquarters Table 24. Manufacturers Human VEGF Antibody Product Offered Table 25. Date of Manufacturers Enter into Human VEGF Antibody Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Human VEGF Antibody Sales by Type (2016-2021) & (Kg) Table 28. Global Human VEGF Antibody Sales by Type (2022-2027) & (Kg) Table 29. Global Human VEGF Antibody Sales Share by Type (2016-2021) Table 30. Global Human VEGF Antibody Sales Share by Type (2022-2027) Table 31. Global Human VEGF Antibody Revenue by Type (2016-2021) & (US$ Million) Table 32. Global Human VEGF Antibody Revenue by Type (2022-2027) & (US$ Million) Table 33. Global Human VEGF Antibody Revenue Share by Type (2016-2021) Table 34. Global Human VEGF Antibody Revenue Share by Type (2022-2027) Table 35. Human VEGF Antibody Price by Type (2016-2021) & (USD/g) Table 36. Global Human VEGF Antibody Price Forecast by Type (2022-2027) & (USD/g) Table 37. Global Human VEGF Antibody Sales by Application (2016-2021) & (Kg) Table 38. Global Human VEGF Antibody Sales by Application (2022-2027) & (Kg) Table 39. Global Human VEGF Antibody Sales Share by Application (2016-2021) Table 40. Global Human VEGF Antibody Sales Share by Application (2022-2027) Table 41. Global Human VEGF Antibody Revenue by Application (2016-2021) & (US$ Million) Table 42. Global Human VEGF Antibody Revenue by Application (2022-2027) & (US$ Million) Table 43. Global Human VEGF Antibody Revenue Share by Application (2016-2021) Table 44. Global Human VEGF Antibody Revenue Share by Application (2022-2027) Table 45. Human VEGF Antibody Price by Application (2016-2021) & (USD/g) Table 46. Global Human VEGF Antibody Price Forecast by Application (2022-2027) & (USD/g) Table 47. North America Human VEGF Antibody Sales by Type (2016-2021) & (Kg) Table 48. North America Human VEGF Antibody Sales by Type (2022-2027) & (Kg) Table 49. North America Human VEGF Antibody Revenue by Type (2016-2021) & (US$ Million) Table 50. North America Human VEGF Antibody Revenue by Type (2022-2027) & (US$ Million) Table 51. North America Human VEGF Antibody Sales by Application (2016-2021) & (Kg) Table 52. North America Human VEGF Antibody Sales by Application (2022-2027) & (Kg) Table 53. North America Human VEGF Antibody Revenue by Application (2016-2021) & (US$ Million) Table 54. North America Human VEGF Antibody Revenue by Application (2022-2027) & (US$ Million) Table 55. North America Human VEGF Antibody Sales by Country (2016-2021) & (Kg) Table 56. North America Human VEGF Antibody Sales by Country (2022-2027) & (Kg) Table 57. North America Human VEGF Antibody Revenue by Country (2016-2021) & (US$ Million) Table 58. North America Human VEGF Antibody Revenue by Country (2022-2027) & (US$ Million) Table 59. Europe Human VEGF Antibody Sales by Type (2016-2021) & (Kg) Table 60. Europe Human VEGF Antibody Sales by Type (2022-2027) & (Kg) Table 61. Europe Human VEGF Antibody Revenue by Type (2016-2021) & (US$ Million) Table 62. Europe Human VEGF Antibody Revenue by Type (2022-2027) & (US$ Million) Table 63. Europe Human VEGF Antibody Sales by Application (2016-2021) & (Kg) Table 64. Europe Human VEGF Antibody Sales by Application (2022-2027) & (Kg) Table 65. Europe Human VEGF Antibody Revenue by Application (2016-2021) & (US$ Million) Table 66. Europe Human VEGF Antibody Revenue by Application (2022-2027) & (US$ Million) Table 67. Europe Human VEGF Antibody Sales by Country (2016-2021) & (Kg) Table 68. Europe Human VEGF Antibody Sales by Country (2022-2027) & (Kg) Table 69. Europe Human VEGF Antibody Revenue by Country (2016-2021) & (US$ Million) Table 70. Europe Human VEGF Antibody Revenue by Country (2022-2027) & (US$ Million) Table 71. Asia Pacific Human VEGF Antibody Sales by Type (2016-2021) & (Kg) Table 72. Asia Pacific Human VEGF Antibody Sales by Type (2022-2027) & (Kg) Table 73. Asia Pacific Human VEGF Antibody Revenue by Type (2016-2021) & (US$ Million) Table 74. Asia Pacific Human VEGF Antibody Revenue by Type (2022-2027) & (US$ Million) Table 75. Asia Pacific Human VEGF Antibody Sales by Application (2016-2021) & (Kg) Table 76. Asia Pacific Human VEGF Antibody Sales by Application (2022-2027) & (Kg) Table 77. Asia Pacific Human VEGF Antibody Revenue by Application (2016-2021) & (US$ Million) Table 78. Asia Pacific Human VEGF Antibody Revenue by Application (2022-2027) & (US$ Million) Table 79. Asia Pacific Human VEGF Antibody Sales by Region (2016-2021) & (Kg) Table 80. Asia Pacific Human VEGF Antibody Sales by Region (2022-2027) & (Kg) Table 81. Asia Pacific Human VEGF Antibody Revenue by Region (2016-2021) & (US$ Million) Table 82. Asia Pacific Human VEGF Antibody Revenue by Region (2022-2027) & (US$ Million) Table 83. Latin America Human VEGF Antibody Sales by Type (2016-2021) & (Kg) Table 84. Latin America Human VEGF Antibody Sales by Type (2022-2027) & (Kg) Table 85. Latin America Human VEGF Antibody Revenue by Type (2016-2021) & (US$ Million) Table 86. Latin America Human VEGF Antibody Revenue by Type (2022-2027) & (US$ Million) Table 87. Latin America Human VEGF Antibody Sales by Application (2016-2021) & (Kg) Table 88. Latin America Human VEGF Antibody Sales by Application (2022-2027) & (Kg) Table 89. Latin America Human VEGF Antibody Revenue by Application (2016-2021) & (US$ Million) Table 90. Latin America Human VEGF Antibody Revenue by Application (2022-2027) & (US$ Million) Table 91. Latin America Human VEGF Antibody Sales by Country (2016-2021) & (Kg) Table 92. Latin America Human VEGF Antibody Sales by Country (2022-2027) & (Kg) Table 93. Latin America Human VEGF Antibody Revenue by Country (2016-2021) & (US$ Million) Table 94. Latin America Human VEGF Antibody Revenue by Country (2022-2027) & (US$ Million) Table 95. Middle East and Africa Human VEGF Antibody Sales by Type (2016-2021) & (Kg) Table 96. Middle East and Africa Human VEGF Antibody Sales by Type (2022-2027) & (Kg) Table 97. Middle East and Africa Human VEGF Antibody Revenue by Type (2016-2021) & (US$ Million) Table 98. Middle East and Africa Human VEGF Antibody Revenue by Type (2022-2027) & (US$ Million) Table 99. Middle East and Africa Human VEGF Antibody Sales by Application (2016-2021) & (Kg) Table 100. Middle East and Africa Human VEGF Antibody Sales by Application (2022-2027) & (Kg) Table 101. Middle East and Africa Human VEGF Antibody Revenue by Application (2016-2021) & (US$ Million) Table 102. Middle East and Africa Human VEGF Antibody Revenue by Application (2022-2027) & (US$ Million) Table 103. Middle East and Africa Human VEGF Antibody Sales by Country (2016-2021) & (Kg) Table 104. Middle East and Africa Human VEGF Antibody Sales by Country (2022-2027) & (Kg) Table 105. Middle East and Africa Human VEGF Antibody Revenue by Country (2016-2021) & (US$ Million) Table 106. Middle East and Africa Human VEGF Antibody Revenue by Country (2022-2027) & (US$ Million) Table 107. Thermo Fisher Corporation Information Table 108. Thermo Fisher Description and Major Businesses Table 109. Thermo Fisher Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 110. Thermo Fisher Human VEGF Antibody Product Table 111. Thermo Fisher Recent Developments Table 112. MilliporeSigma Corporation Information Table 113. MilliporeSigma Description and Major Businesses Table 114. MilliporeSigma Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 115. MilliporeSigma Human VEGF Antibody Product Table 116. MilliporeSigma Recent Developments Table 117. Santa Cruz Biotechnology Corporation Information Table 118. Santa Cruz Biotechnology Description and Major Businesses Table 119. Santa Cruz Biotechnology Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 120. Santa Cruz Biotechnology Human VEGF Antibody Product Table 121. Santa Cruz Biotechnology Recent Developments Table 122. Abcam Corporation Information Table 123. Abcam Description and Major Businesses Table 124. Abcam Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 125. Abcam Human VEGF Antibody Product Table 126. Abcam Recent Developments Table 127. R&D Systems Corporation Information Table 128. R&D Systems Description and Major Businesses Table 129. R&D Systems Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 130. R&D Systems Human VEGF Antibody Product Table 131. R&D Systems Recent Developments Table 132. Novus Biologicals Corporation Information Table 133. Novus Biologicals Description and Major Businesses Table 134. Novus Biologicals Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 135. Novus Biologicals Human VEGF Antibody Product Table 136. Novus Biologicals Recent Developments Table 137. Abnova Corporation Information Table 138. Abnova Description and Major Businesses Table 139. Abnova Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 140. Abnova Human VEGF Antibody Product Table 141. Abnova Recent Developments Table 142. ImmunoStar Corporation Information Table 143. ImmunoStar Description and Major Businesses Table 144. ImmunoStar Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 145. ImmunoStar Human VEGF Antibody Product Table 146. ImmunoStar Recent Developments Table 147. OriGene Corporation Information Table 148. OriGene Description and Major Businesses Table 149. OriGene Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 150. OriGene Human VEGF Antibody Product Table 151. OriGene Recent Developments Table 152. LifeSpan Biosciences Corporation Information Table 153. LifeSpan Biosciences Description and Major Businesses Table 154. LifeSpan Biosciences Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 155. LifeSpan Biosciences Human VEGF Antibody Product Table 156. LifeSpan Biosciences Recent Developments Table 157. Sino Biological Corporation Information Table 158. Sino Biological Description and Major Businesses Table 159. Sino Biological Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 160. Sino Biological Human VEGF Antibody Product Table 161. Sino Biological Recent Developments Table 162. Bio-Rad Corporation Information Table 163. Bio-Rad Description and Major Businesses Table 164. Bio-Rad Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 165. Bio-Rad Human VEGF Antibody Product Table 166. Bio-Rad Recent Developments Table 167. BioLegend Corporation Information Table 168. BioLegend Description and Major Businesses Table 169. BioLegend Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 170. BioLegend Human VEGF Antibody Product Table 171. BioLegend Recent Developments Table 172. Rockland Immunochemicals Corporation Information Table 173. Rockland Immunochemicals Description and Major Businesses Table 174. Rockland Immunochemicals Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 175. Rockland Immunochemicals Human VEGF Antibody Product Table 176. Rockland Immunochemicals Recent Developments Table 177. Agrisera Corporation Information Table 178. Agrisera Description and Major Businesses Table 179. Agrisera Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 180. Agrisera Human VEGF Antibody Product Table 181. Agrisera Recent Developments Table 182. Boster Corporation Information Table 183. Boster Description and Major Businesses Table 184. Boster Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 185. Boster Human VEGF Antibody Product Table 186. Boster Recent Developments Table 187. ProMab Corporation Information Table 188. ProMab Description and Major Businesses Table 189. ProMab Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 190. ProMab Human VEGF Antibody Product Table 191. ProMab Recent Developments Table 192. Creative Biomart Corporation Information Table 193. Creative Biomart Description and Major Businesses Table 194. Creative Biomart Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 195. Creative Biomart Human VEGF Antibody Product Table 196. Creative Biomart Recent Developments Table 197. Enzo Life Sciences Corporation Information Table 198. Enzo Life Sciences Description and Major Businesses Table 199. Enzo Life Sciences Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 200. Enzo Life Sciences Human VEGF Antibody Product Table 201. Enzo Life Sciences Recent Developments Table 202. Bon Opus Biosciences Corporation Information Table 203. Bon Opus Biosciences Description and Major Businesses Table 204. Bon Opus Biosciences Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 205. Bon Opus Biosciences Human VEGF Antibody Product Table 206. Bon Opus Biosciences Recent Developments Table 207. Absolute Antibody Corporation Information Table 208. Absolute Antibody Description and Major Businesses Table 209. Absolute Antibody Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 210. Absolute Antibody Human VEGF Antibody Product Table 211. Absolute Antibody Recent Developments Table 212. US Biological Corporation Information Table 213. US Biological Description and Major Businesses Table 214. US Biological Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 215. US Biological Human VEGF Antibody Product Table 216. US Biological Recent Developments Table 217. Key Raw Materials Lists Table 218. Raw Materials Key Suppliers Lists Table 219. Human VEGF Antibody Distributors List Table 220. Human VEGF Antibody Customers List Table 221. Human VEGF Antibody Market Trends Table 222. Human VEGF Antibody Market Drivers Table 223. Human VEGF Antibody Market Challenges Table 224. Human VEGF Antibody Market Restraints Table 225. Research Programs/Design for This Report Table 226. Key Data Information from Secondary Sources Table 227. Key Data Information from Primary Sources List of Figures Figure 1. Human VEGF Antibody Product Picture Figure 2. Global Human VEGF Antibody Market Share by Type in 2020 & 2027 Figure 3. Rabbit Product Picture Figure 4. Mouse Product Picture Figure 5. Goat Product Picture Figure 6. Others Product Picture Figure 7. Global Human VEGF Antibody Sales Market Share by Application in 2020 & 2027 Figure 8. Laboratory Figure 9. Hospital Figure 10. Others Figure 11. Human VEGF Antibody Report Years Considered Figure 12. Global Human VEGF Antibody Sales 2016-2027 (Kg) Figure 13. Global Human VEGF Antibody Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Human VEGF Antibody Revenue 2016-2027 (US$ Million) Figure 15. Global Human VEGF Antibody Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 16. Global Human VEGF Antibody Sales Market Share by Region (2016-2021) Figure 17. Global Human VEGF Antibody Sales Market Share by Region (2022-2027) Figure 18. North America Human VEGF Antibody Sales YoY (2016-2027) & (Kg) Figure 19. North America Human VEGF Antibody Revenue YoY (2016-2027) & (US$ Million) Figure 20. Europe Human VEGF Antibody Sales YoY (2016-2027) & (Kg) Figure 21. Europe Human VEGF Antibody Revenue YoY (2016-2027) & (US$ Million) Figure 22. Asia-Pacific Human VEGF Antibody Sales YoY (2016-2027) & (Kg) Figure 23. Asia-Pacific Human VEGF Antibody Revenue YoY (2016-2027) & (US$ Million) Figure 24. Latin America Human VEGF Antibody Sales YoY (2016-2027) & (Kg) Figure 25. Latin America Human VEGF Antibody Revenue YoY (2016-2027) & (US$ Million) Figure 26. Middle East & Africa Human VEGF Antibody Sales YoY (2016-2027) & (Kg) Figure 27. Middle East & Africa Human VEGF Antibody Revenue YoY (2016-2027) & (US$ Million) Figure 28. The Top 10 and Top 5 Players Market Share by Human VEGF Antibody Sales in 2020 Figure 29. The Top 10 and Top 5 Players Market Share by Human VEGF Antibody Revenue in 2020 Figure 30. Human VEGF Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 31. Global Human VEGF Antibody Sales Market Share by Type (2016-2027) Figure 32. Global Human VEGF Antibody Revenue Market Share by Type (2016-2027) Figure 33. Global Human VEGF Antibody Sales Market Share by Application (2016-2027) Figure 34. Global Human VEGF Antibody Revenue Market Share by Application (2016-2027) Figure 35. North America Human VEGF Antibody Sales Market Share by Type (2016-2027) Figure 36. North America Human VEGF Antibody Revenue Market Share by Type (2016-2027) Figure 37. North America Human VEGF Antibody Sales Market Share by Application (2016-2027) Figure 38. North America Human VEGF Antibody Revenue Market Share by Application (2016-2027) Figure 39. North America Human VEGF Antibody Sales Share by Country (2016-2027) Figure 40. North America Human VEGF Antibody Revenue Share by Country (2016-2027) Figure 41. U.S. Human VEGF Antibody Revenue (2016-2027) & (US$ Million) Figure 42. Canada Human VEGF Antibody Revenue (2016-2027) & (US$ Million) Figure 43. Europe Human VEGF Antibody Sales Market Share by Type (2016-2027) Figure 44. Europe Human VEGF Antibody Revenue Market Share by Type (2016-2027) Figure 45. Europe Human VEGF Antibody Sales Market Share by Application (2016-2027) Figure 46. Europe Human VEGF Antibody Revenue Market Share by Application (2016-2027) Figure 47. Europe Human VEGF Antibody Sales Share by Country (2016-2027) Figure 48. Europe Human VEGF Antibody Revenue Share by Country (2016-2027) Figure 49. Germany Human VEGF Antibody Revenue (2016-2027) & (US$ Million) Figure 50. France Human VEGF Antibody Revenue (2016-2027) & (US$ Million) Figure 51. U.K. Human VEGF Antibody Revenue (2016-2027) & (US$ Million) Figure 52. Italy Human VEGF Antibody Revenue (2016-2027) & (US$ Million) Figure 53. Russia Human VEGF Antibody Revenue (2016-2027) & (US$ Million) Figure 54. Asia Pacific Human VEGF Antibody Sales Market Share by Type (2016-2027) Figure 55. Asia Pacific Human VEGF Antibody Revenue Market Share by Type (2016-2027) Figure 56. Asia Pacific Human VEGF Antibody Sales Market Share by Application (2016-2027) Figure 57. Asia Pacific Human VEGF Antibody Revenue Market Share by Application (2016-2027) Figure 58. Asia Pacific Human VEGF Antibody Sales Share by Region (2016-2027) Figure 59. Asia Pacific Human VEGF Antibody Revenue Share by Region (2016-2027) Figure 60. China Human VEGF Antibody Revenue (2016-2027) & (US$ Million) Figure 61. Japan Human VEGF Antibody Revenue (2016-2027) & (US$ Million) Figure 62. South Korea Human VEGF Antibody Revenue (2016-2027) & (US$ Million) Figure 63. India Human VEGF Antibody Revenue (2016-2027) & (US$ Million) Figure 64. Australia Human VEGF Antibody Revenue (2016-2027) & (US$ Million) Figure 65. Taiwan Human VEGF Antibody Revenue (2016-2027) & (US$ Million) Figure 66. Indonesia Human VEGF Antibody Revenue (2016-2027) & (US$ Million) Figure 67. Thailand Human VEGF Antibody Revenue (2016-2027) & (US$ Million) Figure 68. Malaysia Human VEGF Antibody Revenue (2016-2027) & (US$ Million) Figure 69. Philippines Human VEGF Antibody Revenue (2016-2027) & (US$ Million) Figure 70. Latin America Human VEGF Antibody Sales Market Share by Type (2016-2027) Figure 71. Latin America Human VEGF Antibody Revenue Market Share by Type (2016-2027) Figure 72. Latin America Human VEGF Antibody Sales Market Share by Application (2016-2027) Figure 73. Latin America Human VEGF Antibody Revenue Market Share by Application (2016-2027) Figure 74. Latin America Human VEGF Antibody Sales Share by Country (2016-2027) Figure 75. Latin America Human VEGF Antibody Revenue Share by Country (2016-2027) Figure 76. Mexico Human VEGF Antibody Revenue (2016-2027) & (US$ Million) Figure 77. Brazil Human VEGF Antibody Revenue (2016-2027) & (US$ Million) Figure 78. Argentina Human VEGF Antibody Revenue (2016-2027) & (US$ Million) Figure 79. Middle East and Africa Human VEGF Antibody Sales Market Share by Type (2016-2027) Figure 80. Middle East and Africa Human VEGF Antibody Revenue Market Share by Type (2016-2027) Figure 81. Middle East and Africa Human VEGF Antibody Sales Market Share by Application (2016-2027) Figure 82. Middle East and Africa Human VEGF Antibody Revenue Market Share by Application (2016-2027) Figure 83. Middle East and Africa Human VEGF Antibody Sales Share by Country (2016-2027) Figure 84. Middle East and Africa Human VEGF Antibody Revenue Share by Country (2016-2027) Figure 85. Turkey Human VEGF Antibody Revenue (2016-2027) & (US$ Million) Figure 86. Saudi Arabia Human VEGF Antibody Revenue (2016-2027) & (US$ Million) Figure 87. UAE Human VEGF Antibody Revenue (2016-2027) & (US$ Million) Figure 88. Human VEGF Antibody Value Chain Figure 89. Human VEGF Antibody Production Process Figure 90. Channels of Distribution Figure 91. Distributors Profiles Figure 92. Bottom-up and Top-down Approaches for This Report Figure 93. Data Triangulation Figure 94. Key Executives Interviewed

Thermo Fisher MilliporeSigma Santa Cruz Biotechnology Abcam R&D Systems Novus Biologicals Abnova ImmunoStar OriGene LifeSpan Biosciences Sino Biological Bio-Rad BioLegend Rockland Immunochemicals Agrisera Boster ProMab Creative Biomart Enzo Life Sciences Bon Opus Biosciences Absolute Antibody US Biological